Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 18 de 18
Filtre
1.
Chinese Journal of Medical Genetics ; (6): 452-457, 2023.
Article Dans Chinois | WPRIM | ID: wpr-981769

Résumé

OBJECTIVE@#To explore the clinical and genetic characteristics of a patient with hypertrophic cardiomyopathy as the initial manifestation of Mucopolysaccharidosis type Ⅲ A (MPS Ⅲ A).@*METHODS@#A female patient with MPS Ⅲ A who was admitted to the Affiliated Hospital of Jining Medical University in January 2022 and her family members (seven individuals from three generations) were selected as the study subjects. Clinical data of the proband were collected. Peripheral blood samples of the proband was collected and subjected to whole exome sequencing. Candidate variants were verified by Sanger sequencing. Heparan-N-sulfatase activity was determined for the disease associated with the variant site.@*RESULTS@#The proband was a 49-year-old woman, for whom cardiac MRI has revealed significant thickening (up to 20 mm) of left ventricular wall and delayed gadolinium enhancement at the apical myocardium. Genetic testing revealed that she has harbored compound heterozygous variants in exon 17 of the SGSH gene, namely c.545G>A (p.Arg182His) and c.703G>A (p.Asp235Asn). Based on guidelines from the American College of Medical Genetics and Genomics (ACMG), both variants were predicted to be pathogenic (PM2_Supporting +PM3+PP1Strong+PP3+PP4; PS3+PM1+PM2_Supporting +PM3+PP3+PP4). Sanger sequencing confirmed that her mother was heterozygous for the c.545G>A (p.Arg182His) variant, whilst her father, sisters and her son were heterozygous for the c.703G>A (p.Asp235Asn) variant. Determination of blood leukocyte heparan-N-sulfatase activity suggested that the patient had a low level of 1.6 nmol/(g·h), whilst that of her father, elder and younger sisters and son were all in the normal range.@*CONCLUSION@#The compound heterozygous variants of the SGSH gene probably underlay the MPS ⅢA in this patient, for which hypertrophic cardiomyopathy is an associated phenotype.


Sujets)
Femelle , Humains , Mâle , Adulte d'âge moyen , Cardiomyopathie hypertrophique , Produits de contraste , Peuples d'Asie de l'Est , Gadolinium , Mucopolysaccharidose de type III , Mutation , Pedigree
2.
Arch. argent. pediatr ; 119(2): e138-e141, abril 2021. ilus
Article Dans Espagnol | LILACS, BINACIS | ID: biblio-1152037

Résumé

La mucopolisacaridosis tipo III B es una enfermedad de depósito lisosomal causada por la deficiencia de la enzima N-acetil-alfa-d-glucosaminidasa, implicada en el catabolismo del heparán sulfato, que produce su acúmulo en diversos tejidos. Se presenta a un paciente de 8 años, afectado de mucopolisacaridosis tipo III B, con historia de diarrea crónica y hallazgos endoscópicos e histológicos compatibles con linfangiectasia intestinal. Tras tratamiento dietético con restricción de ácidos grasos de cadena larga y rica en triglicéridos de cadena media, presentó mejoría clínica, mantenida hasta la actualidad.La patogenia de la diarrea crónica en pacientes con mucopolisacaridosis tipo III B es aún desconocida. Debe investigarse la presencia de linfangiectasia intestinal en estos pacientes e iniciar, en caso de confirmarse, un tratamiento dietético adecuado para mejorar así su calidad de vida.


Mucopolysaccharidosis type IIIB is a lysosomal storage disease caused by a deficiency of the N-acetyl-alpha-d-glucosaminidase enzyme involved in the catabolism of heparan sulfate, causing its accumulation in various tissues. We present an 8-year-old patient with mucopolysaccharidosis type IIIB, with a history of chronic diarrhea and endoscopic and histological findings compatible with intestinal lymphangiectasia. After a dietary treatment with a low-fat diet supplemented with medium-chain triglyceride, our patient presents clinical improvement until today. The pathogenesis of chronic diarrhea in patients with mucopolysaccharidosis type IIIB is still unknown. The presence of intestinal lymphangiectasia in these patients should be investigated, and appropriate dietary treatment should be initiated, if confirmed, to improve their quality of life.


Sujets)
Humains , Mâle , Enfant , Lymphangiectasie intestinale/imagerie diagnostique , Maladies lysosomiales , Mucopolysaccharidose de type III , Régime pauvre en graisses , Diarrhée , Lymphangiectasie intestinale/thérapie
3.
Rev. habanera cienc. méd ; 20(2): e3465, mar.-abr. 2021. tab, graf
Article Dans Espagnol | LILACS, CUMED | ID: biblio-1251796

Résumé

Introducción: El Síndrome Sanfilippo B es un error innato en el metabolismo lisosomal, con herencia autosómica recesiva. Se caracteriza por facie ligeramente tosca, deterioro neurológico progresivo y poca repercusión somática, provocado por mutaciones en el gen NAGLU, cuyo locus es 17q21.2. La incidencia internacionalmente es muy baja y en Cuba solo se han diagnosticado siete pacientes desde 1985. Objetivo: Describir las manifestaciones clínicas, bioquímicas y moleculares de un paciente cubano diagnosticado con Síndrome Sanfilippo B. Presentación de Caso: Se describió un paciente de 13 años, cuyas principales manifestaciones clínicas fueron: facie ligeramente tosca, sinofris, alteraciones de conducta y deterioro neurológico progresivo. El trastorno del sueño fue ocasional y frecuente las infecciones respiratorias. Se demostró la presencia de colitis ulcerativa y pólipo intestinal. Se confirmó excreción aumentada de heparán sulfato y disminución de la actividad enzimática N-acetil αD-glucosaminidasa. Se identificó la mutación c.640dupC en el gen NAGLU en homocigosis en el paciente y ambos padres resultaron ser portadores. Conclusiones: Predominaron las alteraciones de conducta, deterioro neurológico progresivo e infecciones respiratorias en el caso reportado; siendo la colitis ulcerativa y el pólipo intestinal un hallazgo no descrito anteriormente para esta enfermedad. Los estudios cromatográficos y enzimáticos resultaron positivos para Sanfilippo B. El genotipo de este paciente resultó ser homocigótico para una nueva variante alélica patogénica en el gen NAGLU. Se demostró la segregación mendeliana de la mutación en la familia(AU)


Introduction: Sanfilippo syndrome type B is an autosomal recessive lysosomal storage disease. The frequent clinical manifestations include slightly coarse facial features, progressive neurodegeneration and mild somatic repercussion caused by mutations in the NAGLU gene, whose locus is 17q21.2. The worldwide incidence is very low and only seven patients have been diagnosed in Cuba since 1985. Objective: To describe clinical, biochemical and molecular characteristics of a Cuban patient with the diagnosis of Sanfilippo Syndrome type B. Case presentation: A 13 years old patient was described. The main clinical manifestations included mild coarse facie, synophrys, behavior disturbances, and progressive neurologic deterioration. Intermittent sleep disturbance and frequent upper respiratory infections were identified. Ulcerative colitis and intestinal polyp were demonstrated. Increased excretion of heparan sulfate and very low N-acetyl α-Dglucosaminidase activity were confirmed. In addition, the presence of mutation c.640dupC in NAGLU gene was identified. The patient had homozygous genotype and both parents were heterozygous. Conclusions: Behavioral alterations, progressive neurological deterioration and respiratory infections predominated in the reported case. Other findings such as ulcerative colitis and intestinal polyps were not previously described in this disease. The chromatographic and enzymatic studies were positive for Sanfilippo type B. This patient's genotype was found to be homozygous for a novel pathogenic allelic variant in the NAGLU gene. Mendelian segregation of the mutation in the family was demonstrated(AU)


Sujets)
Humains , Mâle , Adolescent , Infections de l'appareil respiratoire , Maladies lysosomiales , Mucopolysaccharidose de type III/génétique , Génotype , Mutation/génétique
4.
Rev. Asoc. Odontol. Argent ; 109(1): 34-40, ene.-abr. 2021. ilus, tab
Article Dans Espagnol | LILACS | ID: biblio-1281050

Résumé

Objetivo: Describir las características bucales prevalentes de pacientes argentinos con mucopolisacaridosis (MPS) atendidos en el Servicio de Odontología del Hospital Nacional "Prof. Alejandro Posadas". Materiales y métodos: Se consideraron las historias clínicas de 19 pacientes con diagnóstico de MPS. Se registraron la edad, el sexo, el lugar de residencia, el tipo de MPS y la presencia de retraso madurativo. La muestra estuvo constituida por 13 niños (6,7±3 años) y 6 adultos (26±9 años): 2 eran mujeres (1 con MPS tipo I; 1 con MPS tipo IV A) y 17 eran hombres (15 con MPS tipo 2; 1 con MPS tipo 1; 1 con MPS tipo III); 13 de los pacientes presentaban discapacidad intelectual. Se evaluaron: tipo de dentición, oclusión, macroglosia, hipoplasias del esmalte, tipo de respiración predominante, clase molar y tratamiento realizado. Resultados: Ambos casos con MPS I presentaban mordida abierta anterior y giroversión dental, y solo uno de estos, diastemas, microdoncia, hipoplasias del esmalte, macroglosia y respiración bucal. De los 15 pacientes con MPS II, 11 presentaban mordida abierta anterior (73%), 3 mordida cruzada posterior (20%), 5 giroversión dental (33%), 11 diastemas (73%), 3 retraso en la erupción (20%), 4 hiperplasia gingival (26%), 13 macroglosia (87%), 7 hipoplasias del esmalte (47%), 2 microdoncia (13%), 9 respiración bucal (60%). Se registraron 5 pacientes con clase molar I (33%), 3 con clase molar II (20%), 3 con clase molar III (20%) y en 3 casos no se pudo evaluar (20%). En el paciente con MPS tipo III se halló mordida abierta anterior, diastemas, retraso en la erupción, macroglosia, respiración bucal y clase molar II; y en el caso de MPS tipo IV A, mordida abierta anterior, diastemas, hiperplasia gingival, macroglosia y clase molar II. El 90% de los pacientes requirió tratamiento odontológico (AU)


Aim: To identify the most prevalent oral manifestations of 19 Argentine patients with mucopolysaccharidos (MPS) attending the Dentistry Service of the National Posadas Hospital. Materials and methods: The medical records of 19 patients diagnosed with MPS were considered. Age, sex, place of residence, type of MPS, and presence of maturational delay were recorded. The sample consisted of 13 children (6.7 ± 3 years) and 6 adults (26 ± 9 years): 2 were women (1 with MPS type I; 1 with MPS type IV A) and 17 were men (15 with MPS type 2; 1 with MPS type 1; 1 with MPS type III); 13 of the patients had intellectual disabilities. The following were evaluated: type of dentition, occlusion, macroglossia, enamel hypoplasia, predominant type of respiration, molar class and treatment performed Results: Both cases with MPS I presented anterior open bite and dental gyroversion, and only one of these, diastemas, microdontia, enamel hypoplasia, macroglossia and mouth respiration. Of the 15 patients with MPS II, 11 presented anterior open bite (73%), 3 posterior crossbite (20%), 5 dental gyroversion (33%), 11 diastemas (73%), 3 delayed eruption (20%), 4 gingival hyperplasia (26%), 13 macroglossia (87%), 7 enamel hypoplasia (47%), 2 microdontia (13%), 9 mouth breathing (60%). 5 patients with molar class I (33%), 3 with molar class II (20%), 3 with molar class III (20%) and in 3 cases it could not be evaluated (20%). In the patient with type III MPS, anterior open bite, diastemas, delayed eruption, macroglossia, mouth breathing and molar class II were found; and in the case of type IV A MPS, anterior open bite, diastemas, gingival hyperplasia, macroglossia and molar class II. 90% of the patients required dental treatment. Conclusion: The most observed oral manifestations were macroglossia (84.2%) and anterior open bite (73%) (AU)


Sujets)
Humains , Mâle , Femelle , Enfant , Adolescent , Adulte , Manifestations buccales , Mucopolysaccharidose de type II/anatomopathologie , Mucopolysaccharidose de type I/anatomopathologie , Mucopolysaccharidose de type III/anatomopathologie , Argentine , Épidémiologie Descriptive , Études transversales , Béance dentaire/épidémiologie , Service hospitalier d'odontologie/statistiques et données numériques , Distribution de L'âge et du Sexe , Macroglossie/épidémiologie , Malocclusion dentaire/épidémiologie
5.
Article Dans Anglais, Portugais | LILACS, SES-SP | ID: biblio-1136775

Résumé

ABSTRACT Objective: To report a rare case of mucopolysaccharidosis IIIB in a pediatric patient, with emphasis on the description of the clinical manifestations and the early diagnosis. Case description: A 14-year-old male patient, who presented regression of neuropsychomotor development since his three years and six months old, with speech loss and frequent falls, evolving with behavioral changes, with agitation and aggressiveness. Although being diagnosed with autism, there was no response to the established treatment; he was subsequently submitted to metabolic investigation, which lead to the diagnosis of Mucopolysaccharidosis IIIB. Comments: Identifying a metabolic disorder requires connecting multiple signs and symptoms, as well as eliminating other apparent causes. MPS IIIB is a diagnostic challenge, particularly in the early stages and in the absence of a family history of the disease.


RESUMO Objetivo: Relatar o caso raro de um paciente pediátrico com mucopolissacaridose III B, com ênfase na descrição de manifestações clínicas. Descrição do caso: Paciente masculino de 14 anos que, a partir dos 3 anos e 6 meses de idade, apresentou regressão do desenvolvimento neuropsicomotor, com perda da fala e quedas frequentes, evoluindo com alterações comportamentais, agitação e agressividade. Diagnosticado como autista, não obteve resposta ao tratamento estabelecido, sendo posteriormente submetido à investigação metabólica, que evidenciou o diagnóstico de mucopolissacaridose III B. Comentários: A identificação de um distúrbio metabólico exige conectar vários sinais e sintomas, além de eliminar outras causas aparentes. A mucopolissacaridose III B é um desafio diagnóstico, particularmente nos estágios iniciais e na ausência de história familiar da doença.


Sujets)
Humains , Mâle , Adolescent , Mucopolysaccharidose de type III/diagnostic , Acetylglucosaminidase/déficit , Mucopolysaccharidose de type III/physiopathologie , Erreurs de diagnostic , Trouble du spectre autistique/diagnostic
6.
Rev. salud pública ; 19(1): 32-38, ene.-feb. 2017. tab
Article Dans Espagnol | LILACS | ID: biblio-903067

Résumé

RESUMEN Objetivo Explorar la presencia de patología genética sindrómica en el Departamento de Boyacá, mediante un acercamiento de medicina genética comunitaria. Materiales y Métodos Un grupo conformado por genetistas, neurólogo pediátrico y genetista bioquímico, llevó a cabo jornadas clínicas en las cuales se evaluaron pacientes con sospecha de enfermedad genética. Se obtuvieron datos demográficos, epidemiológicos y clínicos y se realizó el cálculo de frecuencias de los mismos. En los centros de referencia visitados se realizaron actividades de capacitación al personal médico. Resultados Se encontraron dos agrupamientos genéticos: MPSIII y Síndrome de Ellis Van Creveld, con incidencias mayores a lo reportado en la literatura, además una alta frecuencia de patologías de herencia autosómica recesiva, así como sospecha de síndromes de microdeleción-microduplicación. Conclusiones Se deben establecer mecanismos no convencionales de atención médica para facilitar el acceso a las comunidades a un diagnóstico y tratamiento adecuados en genética. Se espera que el apoyo brindado a los pacientes, familias y personal asistencial de los hospitales a través de las jornadas clínicas y la capacitación, permitan alcanzar este objetivo y a la vez sea un punto de inicio de procesos de prevención primaria y secundaria.(AU)


ABSTRACT Objectives To explore the incidence of syndromic genetic pathologies in Boyacá, Colombia, through a community genetics approach. Materials and Methods A group made up by different medical specialists (geneticists, a pediatric neurologist, and a biochemical geneticist) developed clinical campaigns, in which patients with clinical suspicion of genetic diseases were involved. Demographic, epidemiological and clinical data were collected, and frequency calculations were made based on the collected data. Several training workshops for health personnel were done in each center visited. Results Two genetic clusters were found: mucopolysaccharidosis type III, and Ellis-Van Creveld Syndrome, both of them with higher incidences than those found in the literature. Also, a high frequency of autosomal recessive diseases was found, as well as microdeletion/microduplication syndromes. Conclusions Conventional mechanisms of medical attention must be established, in order to facilitate the access to an appropriate diagnosis and treatment. This work intended to provide support to patients, families and health care services personnel through the workshops and clinical campaigns, and to become a starting point to develop primary and secondary prevention processes.(AU)


Sujets)
Humains , Syndrome d'Ellis-van Creveld/anatomopathologie , Aberrations des chromosomes , Mucopolysaccharidose de type III/anatomopathologie , Erreurs innées du métabolisme/anatomopathologie , Enquêtes de santé , , Colombie/épidémiologie
7.
Korean Journal of Pediatrics ; : S37-S40, 2016.
Article Dans Anglais | WPRIM | ID: wpr-228467

Résumé

Mucopolysaccharidosis type III (MPS III) is a rare genetic disorder caused by lysosomal storage of heparan sulfate. MPS IIIB results from a deficiency in the enzyme alpha-N-acetyl-D-glucosaminidase (NAGLU). Affected patients begin showing behavioral changes, progressive profound mental retardation, and severe disability from the age of 2 to 6 years. We report a patient with MPS IIIB with a long-term follow-up duration. He showed normal development until 3 years. Subsequently, he presented behavioral changes, sleep disturbance, and progressive motor dysfunction. He had been hospitalized owing to recurrent pneumonia and epilepsy with severe cognitive dysfunction. The patient had compound heterozygous c.1444C>T (p.R482W) and c.1675G>T (p.D559Y) variants of NAGLU. Considering that individuals with MPS IIIB have less prominent facial features and skeletal changes, evaluation of long-term clinical course is important for diagnosis. Although no effective therapies for MPS IIIB have been developed yet, early and accurate diagnosis can provide important information for family planning in families at risk of the disorder.


Sujets)
Humains , Diagnostic , Épilepsie , Services de planification familiale , Études de suivi , Héparitine sulfate , Déficience intellectuelle , Maladies lysosomiales , Mucopolysaccharidoses , Mucopolysaccharidose de type III , Pneumopathie infectieuse
8.
Annals of Laboratory Medicine ; : 221-224, 2013.
Article Dans Anglais | WPRIM | ID: wpr-148982

Résumé

Mucopolysaccharidosis (MPS) IIIB is a lysosomal storage disorder (LSD) caused by abnormalities of the enzyme alpha-N-acetylglucosaminidase (NAGLU) that is required for degradation of heparan sulfate. The patient in this study was a 4-yr-old boy. He presented with normal height and weight, pectus carinatum, and multiple persistent Mongolian spots on his back. He had mild dysmorphic features with prominent speech developmental delays and, to a lesser extent, motor developmental delays. The cetylpyridinium chloride precipitation test revealed excessive mucopolysacchariduria (657.2 mg glycosaminoglycan/g creatinine; reference range, C (p.L67P) and c.1444C>T (p.R482W). The c.200T>C mutation was a novel finding. This is the first report of a Korean patient with MPS IIIB who was confirmed by molecular genetic analyses and biochemical investigation.


Sujets)
Enfant d'âge préscolaire , Humains , Mâle , Acetylglucosaminidase/sang , Allèles , Asiatiques/génétique , Chromatographie sur couche mince , Hétérozygote , Leucocytes/métabolisme , Mucopolysaccharidose de type III/diagnostic , Mutation , Réaction de polymérisation en chaîne , République de Corée , Analyse de séquence d'ADN
9.
Annals of Laboratory Medicine ; : 75-79, 2013.
Article Dans Anglais | WPRIM | ID: wpr-119336

Résumé

Mucopolysaccharidosis (MPS) III has 4 enzymatically distinct forms (A, B, C, and D), and MPS IIIC, also known as Sanfilippo C syndrome, is an autosomal recessive lysosomal storage disease caused by a deficiency of heparan acetyl-CoA:alpha-glucosaminide N-acetyltransferase (HGSNAT). Here, we report a case of MPS IIIC that was confirmed by molecular genetic analysis. The patient was a 2-yr-old girl presenting with skeletal deformity, hepatomegaly, and delayed motor development. Urinary excretion of glycosaminoglycan (GAG) was markedly elevated (984.4 mg GAG/g creatinine) compared with the age-specific reference range (A (IVS2+1G>A) and c.1150C>T (p.Arg384*). To the best of our knowledge, this is the first case of MPS IIIC to be confirmed by clinical, biochemical, and molecular genetic findings in Korea.


Sujets)
Enfant d'âge préscolaire , Femelle , Humains , Acetyltransferases/génétique , Asiatiques/génétique , Séquence nucléotidique , Chromatographie sur couche mince , Glycosaminoglycanes/urine , Héparitine sulfate/composition chimique , Leucocytes/immunologie , Mucopolysaccharidose de type III/diagnostic , Mutation , République de Corée , Analyse de séquence d'ADN
10.
Acta bioquím. clín. latinoam ; 44(4): 647-652, dic. 2010. graf, tab
Article Dans Espagnol | LILACS | ID: lil-633133

Résumé

El objetivo de este estudio fue determinar, en una muestra de individuos cubanos, un rango preliminar de valores normales de actividad específica de N-acetil- a-D-glucosaminidasa y arilsulfatasa A, enzimas deficientes en la mucopolisacaridosis tipo III B y la leucodistrofia metacromática, respectivamente. Se realizó una investigación de corte transversal, en muestras de sangre de 38 individuos adultos. Se realizó la extracción de los leucocitos y se determinó la actividad específica de las enzimas por métodos espectrofotométricos. Todos los participantes fueron caracterizados desde el punto de vista clínico como sanos para ambas enfermedades. Se obtuvieron valores medios de actividad específica de N-acetil-a-D-glucosaminidasa y arilsulfatasa A de 1,52±0,30 y 121,37±20,14 nmol/mg/h, respectivamente. No se encontraron diferencias significativas en relación a las características étnicas para ninguna de las dos enzimas (p<0,05). Este constituye el primer estudio cubano en el cual se publican rangos de actividad específica para estas enzimas en individuos cuya condición de sanos y no relacionados familiarmente con la enfermedad ha sido clínicamente demostrada. El análisis de un mayor número de muestras permitirá establecer los puntos de corte que dotarán al diagnóstico bioquímico de estas enfermedades de una mayor confiabilidad.


The aim of this study was to determine, in a sample of Cuban individuals, a preliminary range of normal values of N-acetyl-a-D-glucosaminidase and arylsulfatase A activity, enzymes that are deficient in mucopolysaccharidosis type III B and metachromatic leukodystrophy, respectively. A cross-sectional research was conducted. Blood samples were obtained out of 38 adult individuals. The leucocytes were extracted and the specific enzymatic activity was assayed by spectrophotometric methods. All participants were characterized from the clinical point of view as healthy for both diseases. Average values of N-acetyl-a-D-glucosaminidase and arylsulfatase A specific activities of 1.52 ± 0.30 and 121.37 ± 20.14 nmol/mg/h, respectively were obtained. There were no significant differences related to ethnicity for any of the two enzymes (p <0.05). This is the first Cuban study in which ranges of activity for these enzymes have been reported in healthy individuals whose healthy and non-familiarly related with the disease status have been clinically demonstrated. The analysis of more samples will establish the cutoff points that will increase the reliability of the biochemical diagnosis of these diseases.


Sujets)
Humains , Acetylglucosaminidase , Cerebroside-sulfatase , Enzymes , Valeurs de référence , Acetylglucosaminidase , Mucopolysaccharidose de type III , Adulte , Cuba , Leucodystrophie métachromatique , Erreurs innées du métabolisme
11.
Chinese Journal of Pediatrics ; (12): 407-410, 2008.
Article Dans Chinois | WPRIM | ID: wpr-326124

Résumé

<p><b>OBJECTIVE</b>Mucopolysaccharidosis (MPS) types IIIA, B, C, D are a group of autosomal recessive lysosomal storage disorders caused by mutations in one of four genes which encode enzyme activities required for the lysosomal degradation of heparan sulfate. MPSIIIA and MPSIIIB involve deficiencies of heparan N-sulfatase (SGSH) and alpha-N-acetylglucosaminidase (NAGLU). MPS IIIA and MPS IIIB are more common than MPS IIIC and IIID. The present study aimed to establish two enzyme assay methods for SGSH and NAGLU activities for carrying out postnatal and prenatal diagnosis of MPSIIIA and IIIB by means of SGSH and NAGLU activity assay on plasma, leukocyte, uncultured chorionic villi (CV) and cultured amniotic fluid cells (AF cell) using two newly synthesized substrates. Mutation analysis of SGSH gene was also performed.</p><p><b>METHODS</b>Two fluorigenic substrate (4-methylumbelliferyl-alpha-D-N-sulphoglucosaminide.Na and 4-methylumbelliferyl-alpha-N-acetylglucosaminide) were used for the assay of SGSH and NAGLU activity. SGSH activity in leukocyte was determined for diagnosis MPSIIIA proband. NAGLU activity was determined in plasma for diagnosis of MPSIIIB proband. Twelve cases with MPS III were enrolled in this study, 4 were female and 8 were male, age 3 - 10 years and were from 10 unrelated families. Eight exons of SGSH gene were amplified by PCR. The mutations of the patients were characterized by direct sequencing of the amplified DNA fragments. Prenatal diagnosis in 3 pregnancies at risk was carried out according to NAGLU activity on uncultured CV at 11th week or on cultured AF cell at 18th week of gestation.</p><p><b>RESULTS</b>The SGSH activities in leukocyte of normal controls were 4.4 - 8.1 nmol/(17 h.mg protein). The NAGLU activity in plasma of normal controls was 33.3 - 62.4 nmol/(4 h.ml). The NAGLU activities were 44.9 - 91.7 nmol/(17 h.mg protein) and 53.2 - 82.2 nmol/(17 h.mg protein) in CV and cultured AF cells respectively. Five cases of MPS IIIB and 7 cases of MPS IIIA were diagnosed. The mutation analysis of SGSH gene showed 6 mutations (G191R, D235N, R377C, E447K, R233X and D219Wfs264X), only one of which (D219Wfs264X) has not been previously reported. Prenatal diagnosis was performed on 3 pregnancies at risk. NAGLU activity of one affected fetus was 1.5 nmol/(17 h.mg protein) in AF cell.</p><p><b>CONCLUSIONS</b>The method using synthesized fluorigenic 4-methylumbelliferyl-substrates were sensitive, rapid and convenient assay of SGSH and NAGLU activity and were reliable for early prenatal diagnosis. Mutation analysis on MPS IIIA patients suggests new possibilities for molecular diagnosis of the disease.</p>


Sujets)
Enfant , Enfant d'âge préscolaire , Femelle , Humains , Mâle , Grossesse , Acetylglucosaminidase , Génétique , Analyse de mutations d'ADN , Diagnostic différentiel , Mucopolysaccharidose de type III , Diagnostic , Génétique , Mutation , Diagnostic prénatal , Sulfuric ester hydrolases , Génétique
12.
Indian Pediatr ; 2006 May; 43(5): 437-40
Article Dans Anglais | IMSEAR | ID: sea-13824

Résumé

Mucopolysaccharidoses are characterized by involvement of multiple organs, including blood vessels. We present a case of mucopolysaccharidosis IIIB admitted with recurrent subdural hematoma; further evaluation and dural biopsy revealed an association with cerebral vasculopathy.


Sujets)
Enfant d'âge préscolaire , Femelle , Hématome subdural/étiologie , Humains , Mucopolysaccharidose de type III/complications , Récidive , Vascularite du système nerveux central/étiologie
13.
Article Dans Portugais | LILACS, BBO | ID: lil-472503

Résumé

As mucopolissacaridoses são um grupo de doenças metabólicas raras, sendo dos seis tipos existentes o tipo III a Síndrome de Sanfilippo a mais comumente encontrada. Nesta síndrome, a ausência de enzima alfa glicosaminidase faz com que haja um acúmulo de determinado mucopolissacarídeo no organismo, trazendo conseqüências graves ao desenvolvimento neuropsicomotor do paciente. Este artigo descreve o caso clínico de um paciente portador da síndrome de SANFILIPPO, suas características e as limitações que este quadro oferece ao atendimento odontológico.


Sujets)
Humains , Mâle , Adolescent , Mucopolysaccharidose de type III/diagnostic , Mucopolysaccharidose de type VII/complications , Agitation psychomotrice , Diagnostic différentiel , Incapacité professionnelle
14.
Korean Journal of Pediatrics ; : 1132-1138, 2005.
Article Dans Anglais | WPRIM | ID: wpr-178932

Résumé

PURPOSE: The mucopolysaccharidoses (MPSs) are a heterogeneous group of lysosomal storage disorders. They are caused by a deficiency of the enzymes involved in the degradation of glycosaminoglycans. Early recognition is important because recombinant enzyme replacement therapy is now available for MPS. We studied the clinical characteristics of 80 MPS children with the object of determining the epidemiological, clinical and radiological features in Korean MPS children. METHODS: Diagnosis of MPS was confirmed by skin fibroblast enzyme analysis in 80 patients between February 1995 and December 2004. Charts were retrospectively reviewed for clinical and radiological findings, as well as for intelligence and speech evaluations. RESULTS: Hunter syndrome (MPS type II) was the most prevalent type, appearing in 51/80 cases (64 %), followed by Sanfilippo syndrome (MPS III-18%), Hurler syndrome (MPS I-15%), and Morquio syndrome (MPS IV-4%). The average age at diagnosis was 5.5 years (range 1 to 20), and the male-to-female ratio was 4.7: 1. Typical radiographic changes were observed in 45/54 cases (83%). Mitral regurgitation was the most common cardiac defect. Moderate to profound mental retardation and hearing loss were present in 14/35 cases (56%) and 33/38 cases (82%), respectively. Four MPS II patients had bone marrow transplantation, with mixed outcomes. Five MPS I patients are currently on enzyme replacement therapy. CONCLUSION: Our study showed a high proportion of MPS II cases (64%), which may represent population variability. By studying the clinical features of these patients, we hope to alert pediatricians of the warning signs of MPS.


Sujets)
Enfant , Humains , Transplantation de moelle osseuse , Diagnostic , Thérapie enzymatique substitutive , Fibroblastes , Glycosaminoglycanes , Perte d'audition , Espoir , Incidence , Déficience intellectuelle , Intelligence , Corée , Insuffisance mitrale , Mucopolysaccharidoses , Mucopolysaccharidose de type I , Mucopolysaccharidose de type II , Mucopolysaccharidose de type III , Mucopolysaccharidose de type IV , Études rétrospectives , Peau
15.
Bol. méd. Hosp. Infant. Méx ; 57(12): 697-704, dic. 2000. ilus, tab
Article Dans Espagnol | LILACS | ID: lil-286303

Résumé

Introducción. Las mucopolisacaridosis (MPS) son un grupo heterogéneo de enfermedades hereditarias, originadas por la deficiencia de enzimas lisosomales que catalizan la degradación de los glucosaminoglucanos (GAGs). Actualmente se conocen 11 deficiencias enzimáticas que originan 8 fenotipos distintos y expresan una variedad de síntomas clínicos. Material y métodos. Doce pacientes con diagnóstico clínico de MPS (4 con MPS I, 2 con MPS IIIB y 6 con MPS VI) dos fueron estudiados bioquímicamente mediante la cuantificación de GAGs urinarios, su identificación a través de electroforesis en acetato de celulosa y la correlación con la actividad enzimática en leucocitos. Resultados. En todos los casos la concentración de GAGs/creatinina estuvo elevada en comparación con un grupo control. La electroforesis reveló la presencia de los GAGs esperados en cada tipo de MPS y la actividad enzimática fue deficiente en los 12 pacientes estudiados. Conclusiones. La aplicación de los métodos anteriores en pacientes con MPS, es una poderosa herramienta a utilizar como diagnóstico.


Sujets)
Humains , Mâle , Femelle , Enfant d'âge préscolaire , Glycosaminoglycanes/urine , Mucopolysaccharidose de type III/enzymologie , Mucopolysaccharidose de type I/enzymologie , Mucopolysaccharidose de type VI/enzymologie , Activation enzymatique , Maladies génétiques congénitales/enzymologie , Lysosomes
16.
Indian J Pediatr ; 1993 Jul-Aug; 60(4): 595-7
Article Dans Anglais | IMSEAR | ID: sea-80493
17.
Rev. Hosp. Psiquiátr. La Habana ; 33(1): 57-61, ene.-jun. 1992.
Article Dans Espagnol | LILACS | ID: lil-118688

Résumé

Se informa un paciente con este trastorno metabólico clasificado en base a los elementos clínicos y radiológicos. Se revisa el tema brevemente exponiendo cada síndrome con sus caracteres en cuanto al aspecto clínico, error enzimático, edad de aparición, alteraciones radiológicas y patrón de herencia que lo determina


Sujets)
Enfant , Humains , Mâle , Mucopolysaccharidose de type III
18.
Rev. bras. neurol ; 24(5): 135-8, set.-out. 1988. ilus, tab
Article Dans Portugais | LILACS | ID: lil-72377

Résumé

Os autores apresentam dois casos de doença de Sanfilippo, um do tipo A e outro do tipo B, com seus achados clínicos, laboratoriais, radiológicos, ultrastruturais e enzimáticos. Procuram chamar a atençäo para esta forma particular de mucospolissacaridose em que as manifestaçöes neurológicas säo evidentes, enquanto que as alteraçöes esqueléticas e viscerais, características deste grupo de doenças, säo discretas ou moderadas, o que pode dificultar o seu reconhecimento


Sujets)
Nourrisson , Enfant d'âge préscolaire , Humains , Femelle , Mucopolysaccharidose de type III/diagnostic
SÉLECTION CITATIONS
Détails de la recherche